Prelude Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Prelude Therapeutics (PRLD) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Prelude Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Prelude Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Prelude Therapeutics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $6.0k | 4.2k | 1.43 |
| 2025-06-30 | $86k | 104k | 0.83 |
| 2025-03-31 | $75k | 96k | 0.78 |
| 2024-12-31 | $86k | 67k | 1.28 |
| 2024-09-30 | $15k | 7.0k | 2.07 |
| 2024-06-30 | $42k | 11k | 3.80 |
| 2024-03-31 | $74k | 16k | 4.74 |
| 2023-12-31 | $85k | 20k | 4.26 |
| 2023-09-30 | $23k | 7.4k | 3.09 |
| 2023-06-30 | $31k | 6.9k | 4.50 |
| 2023-03-31 | $5.6k | 980 | 5.70 |
| 2022-12-31 | $6.3k | 1.0k | 6.04 |
| 2022-09-30 | $0 | 68 | 0.00 |
| 2022-06-30 | $12k | 2.7k | 4.59 |
| 2022-03-31 | $1.0k | 183 | 5.46 |
| 2021-12-31 | $0 | 1.9k | 0.00 |
| 2021-09-30 | $2.1M | 37k | 55.56 |
| 2021-06-30 | $189k | 7.6k | 25.00 |
| 2021-03-31 | $968k | 22k | 43.32 |
| 2020-12-31 | $215k | 2.6k | 83.33 |
| 2020-09-30 | $43k | 1.4k | 30.22 |